Infants with TCN2 defect may present with megaloblastic anemia, feeding difficulties, developmental delay, microcephaly, failure to thrive, hypotonia, lethargy, irritability, involuntary movements, focal or multifocal seizures, and cerebral atrophy (Benbir et al., 2007). The gene discussed is TCN2; the disease is megaloblastic anemia.